FOR IMMEDIATE RELEASE
New avenues for treatment supported
SALT LAKE CITY, Monday, August 26, 2013 - The Epilepsy Association of Utah (EAU) recognizes the potent nature and reputation cannabis has gained in recent news. While the EAU does not condone the abuse of marijuana or recreational use of marijuana, we note the medical value and potential the extraction of Cannabidiol (CBD) from the plant has for the epilepsy community.
“This isn’t a political issue and it isn’t an ethical issue; this is a medical and public policy issue,” says Jennifer May, EAU Professional Advisory Board Member. She continued, “I never imagined I’d be advocating for high-CBD cannabis, but watching my son seize every day has forced me to become educated and realize the potential this plant extract has for changing lives.”
The EAU believes there is great benefit in the support of any legislative measures allowing the expansion of treatment options, specifically any medical grade product derived from the cannabis plant.
ABOUT THE EPILEPSY ASSOCIATION OF UTAH
Founded in 1973, The Epilepsy Association of Utah is a 501(c)(3) charity dedicated to enhancing the quality of life for all individuals living with Epilepsy and seizure disorders. 1 in 26 people will develop Epilepsy at some time in their lives leading to over 100,000 people in Utah alone. Epilepsy is the 4th most common neurological disorder in the US after migraine, stroke and Alzheimer’s. The Epilepsy Association of Utah offers a public education program, statewide support groups, personal and professional advocacy, college scholarships, art exhibits, educational conferences, summer camp and more. Visit http://epilepsyut.org for additional information.
Press Contact: Annette Maughan